(原标题:复星医药、康方生物最新业绩公布;勃林格殷格翰新药获批 | 动脉“医”周报)Daphne 作者:实习生陈川、郑奥、贺朵1国内企业动态新药进展三生制药个体化rhTPO方案疗效优于艾曲泊帕8月21日,中国医学科学院血液病医院张磊教授团队在《eClinicalMedicine》(《柳叶刀》子刊)发表了“TE-ITP研究”成果。该研究首次头对头比较证实,基于血小板计数的个体化rhTPO给药方案治疗...
Source Link(原标题:复星医药、康方生物最新业绩公布;勃林格殷格翰新药获批 | 动脉“医”周报)Daphne 作者:实习生陈川、郑奥、贺朵1国内企业动态新药进展三生制药个体化rhTPO方案疗效优于艾曲泊帕8月21日,中国医学科学院血液病医院张磊教授团队在《eClinicalMedicine》(《柳叶刀》子刊)发表了“TE-ITP研究”成果。该研究首次头对头比较证实,基于血小板计数的个体化rhTPO给药方案治疗...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.